To examine gene alterations in relation to key patient clinicopathologic variables, we compared somatic genomic profiles across patients grouped according to age at primary cancer diagnosis, menopausal status at primary cancer diagnosis, germline mutation status, type of adjuvant endocrine therapy, molecular subtype, Ki67 index and tumor grade. This evidence concerns the gene MKI67 and neoplasm.